Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study

J Danesh1, L Youngman, S Clark

  • 1Clinical Trial Service Unit, Nuffield Department of Clinical Medicine, University of Oxford, Radcliffe Infirmary, Oxford OX2 6HE. john.danesh@balliol.ox.ac.uk

BMJ (Clinical Research Ed.)
|December 14, 1999
PubMed

Insights

Chronic Helicobacter pylori infection shows a moderate association with coronary heart disease. Further large trials are needed to confirm causality and the effects of H. pylori eradication.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality worldwide.
  • The role of chronic infections, such as Helicobacter pylori (H. pylori), as a potential risk factor for CHD is under investigation.

Purpose of the Study:

  • To investigate the association between chronic Helicobacter pylori infection and the risk of developing coronary heart disease, specifically early-onset myocardial infarction.

Main Methods:

  • A case-control study involving 1122 survivors of myocardial infarction (ages 30-49) and 1122 matched controls.
  • A sibling-pair study of 510 pairs where one sibling had myocardial infarction and the other did not.
  • Serological testing was used to detect chronic H. pylori infection.

Main Results:

  • Individuals with early-onset myocardial infarction had a significantly higher prevalence of H. pylori antibodies (42%) compared to controls (24%), with an initial odds ratio of 2.28.
  • The association remained significant after adjusting for smoking, socioeconomic status, lipids, and obesity, with an adjusted odds ratio of 1.75.
  • The sibling-pair analysis showed a weaker, non-significant association (odds ratio 1.33).

Conclusions:

  • These studies suggest a moderate association between coronary heart disease and H. pylori seropositivity, independent of common risk factors.
  • While the association may be causal, large randomized trials are necessary to confirm this and assess the impact of H. pylori eradication.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...